Recent Finacing
Recent Raise
Hua Medicine is a Shanghai-based clinical-stage biopharma developing therapies for Type 2 diabetes and CNS disorders, advancing dorzagliatin (HMS5552), a 4th-generation glucokinase activator, through late-stage trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Hua Medicine.
